A pilot study conducted by researchers in Rome used monochromatic excimer light (MEL) to treat 37 vitiligo patients twice weekly with MEL for a maximum of six months.
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Losing a Malpractice Case May Depend on Where You Live
The Cutaneous Connection: Treating Atopic Dermatitis in the Winter
The Role We Play in Addressing Racial Disparity in Dermatology
The Mainstream Patient: February 2
2 Clarke Drive Cranbury, NJ 08512